Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
23.46
+0.75 (3.30%)
At close: Nov 4, 2024, 4:00 PM
22.70
-0.76 (-3.24%)
Pre-market: Nov 5, 2024, 6:00 AM EST
Bicycle Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Cash & Equivalents | - | 526.42 | 339.15 | 438.68 | 135.99 | 92.12 | Upgrade
|
| Cash & Short-Term Investments | 961.36 | 526.42 | 339.15 | 438.68 | 135.99 | 92.12 | Upgrade
|
| Cash Growth | 68.05% | 55.22% | -22.69% | 222.58% | 47.63% | 45.34% | Upgrade
|
| Accounts Receivable | - | - | 2.05 | 1 | 5.46 | 0.2 | Upgrade
|
| Other Receivables | - | 24.04 | 19.16 | 10.91 | 9.18 | 6.94 | Upgrade
|
| Receivables | - | 24.04 | 21.21 | 11.91 | 14.63 | 7.15 | Upgrade
|
| Prepaid Expenses | - | 11.41 | 9.02 | 7.97 | 5.1 | 4.88 | Upgrade
|
| Total Current Assets | - | 561.87 | 369.38 | 458.56 | 155.72 | 104.15 | Upgrade
|
| Property, Plant & Equipment | - | 27.68 | 32.77 | 17.79 | 3.61 | 4.35 | Upgrade
|
| Other Long-Term Assets | - | 5.79 | 8.46 | 3.45 | 1.82 | 1.7 | Upgrade
|
| Total Assets | - | 595.34 | 410.61 | 479.79 | 161.15 | 110.19 | Upgrade
|
| Accounts Payable | - | 13.05 | 6.47 | 2.72 | 1.37 | 1.95 | Upgrade
|
| Accrued Expenses | - | 26.38 | 21.86 | 11.29 | 10.58 | 5.44 | Upgrade
|
| Current Portion of Leases | - | 4.88 | 3.13 | 2.38 | 0.84 | 0.64 | Upgrade
|
| Current Unearned Revenue | - | 24.98 | 20.42 | 19.27 | 10.14 | 0.73 | Upgrade
|
| Other Current Liabilities | - | 0.26 | 1.47 | 0.57 | 0.21 | 0.07 | Upgrade
|
| Total Current Liabilities | - | 69.54 | 53.34 | 36.24 | 23.13 | 8.82 | Upgrade
|
| Long-Term Debt | - | 30.7 | 30.32 | 29.87 | 14.51 | - | Upgrade
|
| Long-Term Leases | - | 9.38 | 10.89 | 12.08 | 0.43 | 1.25 | Upgrade
|
| Long-Term Unearned Revenue | - | 110.22 | 41.46 | 52.07 | 25.02 | 4.93 | Upgrade
|
| Other Long-Term Liabilities | - | 4.58 | 3.83 | 3.28 | 2.61 | 2 | Upgrade
|
| Total Liabilities | - | 224.41 | 139.83 | 133.54 | 65.69 | 17 | Upgrade
|
| Common Stock | - | 0.55 | 0.39 | 0.38 | 0.27 | 0.23 | Upgrade
|
| Additional Paid-In Capital | - | 883.45 | 601.11 | 567.64 | 249.95 | 195.06 | Upgrade
|
| Retained Earnings | - | -511.76 | -331.1 | -218.38 | -151.56 | -100.55 | Upgrade
|
| Comprehensive Income & Other | - | -1.3 | 0.39 | -3.39 | -3.19 | -1.54 | Upgrade
|
| Total Common Equity | 873.81 | 370.93 | 270.78 | 346.25 | 95.46 | 93.2 | Upgrade
|
| Shareholders' Equity | 873.81 | 370.93 | 270.78 | 346.25 | 95.46 | 93.2 | Upgrade
|
| Total Liabilities & Equity | - | 595.34 | 410.61 | 479.79 | 161.15 | 110.19 | Upgrade
|
| Total Debt | 42.74 | 44.96 | 44.33 | 44.34 | 15.78 | 1.89 | Upgrade
|
| Net Cash (Debt) | 918.63 | 481.47 | 294.83 | 394.34 | 120.22 | 90.23 | Upgrade
|
| Net Cash Growth | 74.51% | 63.30% | -25.24% | 228.03% | 33.24% | 42.36% | Upgrade
|
| Net Cash Per Share | 17.82 | 13.53 | 9.94 | 15.73 | 6.28 | 8.17 | Upgrade
|
| Filing Date Shares Outstanding | 68.99 | 42.59 | 30.02 | 29.6 | 23.09 | 17.99 | Upgrade
|
| Total Common Shares Outstanding | 68.99 | 42.43 | 29.87 | 29.58 | 21.09 | 17.99 | Upgrade
|
| Working Capital | - | 492.33 | 316.04 | 422.32 | 132.59 | 95.33 | Upgrade
|
| Book Value Per Share | 12.67 | 8.74 | 9.06 | 11.71 | 4.53 | 5.18 | Upgrade
|
| Tangible Book Value | 873.81 | 370.93 | 270.78 | 346.25 | 95.46 | 93.2 | Upgrade
|
| Tangible Book Value Per Share | 12.67 | 8.74 | 9.06 | 11.71 | 4.53 | 5.18 | Upgrade
|
| Machinery | - | 16.91 | 16.24 | 7.11 | 5.97 | 4.68 | Upgrade
|
| Leasehold Improvements | - | 11 | 10.74 | 0.81 | 0.38 | 0.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.